PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders

Volume: 19, Issue: 3, Pages: 913 - 913
Published: Mar 20, 2018
Abstract
Research in recent years on peroxisome proliferator-activated receptor (PPAR)β/δ indicates that it plays a key role in the maintenance of energy homeostasis, both at the cellular level and within the organism as a whole. PPARβ/δ activation might help prevent the development of metabolic disorders, including obesity, dyslipidaemia, type 2 diabetes mellitus and non-alcoholic fatty liver disease. This review highlights research findings on the...
Paper Details
Title
PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
Published Date
Mar 20, 2018
Volume
19
Issue
3
Pages
913 - 913
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.